Citadel Advisors »

Fennec Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Fennec Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fennec Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fennec Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $112k 10k 11.22
2023-09-30 $204k 27k 7.51
2023-06-30 $967k 110k 8.83
2023-03-31 $1.1M 137k 8.32
2022-12-31 $1.7M 178k 9.60
2021-12-31 $65k 15k 4.37
2021-09-30 $157k 17k 9.40
2021-06-30 $83k 11k 7.28
2020-09-30 $82k 14k 6.07
2020-06-30 $257k 31k 8.32
2020-03-31 $63k 11k 5.94